Team:USTC-China
From 2011.igem.org
(Difference between revisions)
Line 22: | Line 22: | ||
<br/> | <br/> | ||
<br/> | <br/> | ||
- | * | + | *<font size="3">successfully built biobricks of vital gene in chemotaxis and compatible riboswitch for theophylline.</font> |
<br/> | <br/> | ||
- | *We have contributed to modulating existing biobrick and take advantage of its flexible ratio in our project. | + | *<font size="3">We have contributed to modulating existing biobrick and take advantage of its flexible ratio in our project.</font> |
<br/> | <br/> | ||
- | *We have developed innovative application of our basic design. | + | *<font size="3">We have developed innovative application of our basic design.</font> |
<html> | <html> | ||
</div> | </div> |
Revision as of 17:40, 28 October 2011
![]() |
|||||||||
![]() |